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various arteries of the male Spontaneously Hypertensive Rat (SHR) - the best animal model for research on human 
hypertension - after treatment with ENALAPRIL and HYDROCHLOROTHIAZID. Untreated male SHR and 
Wistar-Kyoto Rats of the same age were used as controls. The PURPOSE of the investigation was to discover: 
- to what extent changes in the arterial wall due to hypertension can be reversed by antihypertensive drugs 
- whether and to what extem differences in the reaction to ENALAPRIL HYDROCHLOROTHIAZID exist 
- whether changes in the arterial wall due to hypertension may progress to a point at which antihypertensive therapy 
is no longer effective. 
Results: The reactions in the walls of the coronary, basilar, renal, femoral, mesenteric and caudal arteries are not 
identical, but are specific for the different vessels. The morphological response of the wall is, however, similar, in that 
the tunica media responds most strongly with a reduction of the pathological enlargement of the intercellular space 
and by alteration of the ratio of 'k'  to 'in' smooth muscle cells (STAUBESAND, 1982) in favour of the former, 
following treatment with either ENALAPRIL or HYDROCHLOROTHIAZID.Semiquantitative morphological ex- 
amination has also shown that ENALAPRIL offers particularly effective protection against hypertensive damage to 
the wall of the coronary arteries, and HYDROCHLOROTHIAZID to that of the renal arteries.After the appearance 
of calcificatio, foci or osmiophilic shrinkage necroses, however, antihypertensive therapy is no longer effective, and 
these hypertensive changes hould the.,'efore be regarded as irreversible. 
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Evidence is accumulating that part of plasma angiotensin I (AI) is generated at tissue sites and not by circulating 
plasma renin. To address this issue we studied whole-body AI kinetics and regional AI metabolism and production in 
the systemic, pulmonary, and coronary vascular beds of the pig. 
Methods: Highly purified mono-iodinated ]25I-AI was given via constant infusion into the left cardiac ventricle of 8 
captopril-treated and 8 untreated pigs (weight 23-31 kg). The use of ~251-AI for studying the metabolism of 
endogenous AI was validated with combined infusions of labeled and unlebeled AI. 1zsI-AI infusions had no effect on 
heart rate, blood pressure, cardiac output or coronary blood flow. Steady-state plasma levels of intact ~251-AI and 
1251-AII and endogenous AI and AII were measured, after SepPak extraction and HPLC separation, with gamma 
counting and RIA, in the aorta, pulmonary artery, right and left atrium and the great cardiac vein. Plasma renin 
activity (PRA) was also measured at these sampling sites. 
Results: Plasma ~251-AI decay, which was followed after stopping the infusion until levels 5-10% of the steady state 
p.!:~eau had been reached, was mono-exponential with t~/z = 0.95 +_ 0.08 rain (mean + SEM) and 0.40 + 0.05 min with 
and without captopril respectively~ etabolic clearance rates were 5.6 + 0.4 and 14.6 ± 1.6 L/min. Distribution 
volume was equal under both circumstances, 7.7 _+ 0.3 and 7.5 ± 0.4 L (25-30% of body weight), indicating that AI is 
distributed over both plasma and interstitial fluid compartments. Production of extracellular fluid AI (including 
plasma AI) was 127 ± 29 and 47 ± 11 pmol/min with and without captopril, whereas AI production by circulating 
renin was 63 _+ 20 and 10 ± 3 pmol/min. The effect of captopril was predominantly (p < 0.01) on the AI production 
by circulating renin. 
~251-A1 extraction over the the systemic, pulmonary and coronary vascular beds was 57 + 4, 14 ± 4 and 46 ± 4% 
with captopril, and 55 ± 2, 46 ± 5 and 52 ± 5% without captopril. Despite this rapid extraction the levels of 
endogenous AI in the aorta, right atrium and great cardiac vein were not different from each other, both with and 
without captoprfi. Without captopril, AI was lower in tl, left atrium than in the pulmonary artery (p < 0.05). The time 
required for PRA to compensate for AI extraction was 22-24, 2-4 and 13-14 sec in the systemic, pulmonary and 
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coronary vascular beds with and without captopril. Extraction of plasma AI and possible release of AI from tissue into 
plasma re expected to occur at the level of the capillaries. Since capilla,, 3, blood trm~s!t time is only 2-3 sec, net release 
of AI from tissue sites into the systemic and coronary circulations must have occurred. 
Conclusion: A major part. of AI present in extracellular fluid is formed at tissue sites and some of this locally 
produced AI does reach the plasma compartment. Captopril-induced changes in the production of extracellular fluid 
AI at tissue sites do not run in parallel with changes in AI production by circulating renin. These findings may have 
important implications for understanding the mechanism by which drugs interfering with angiotensin formation can 
affect vascular tone. 
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We have previously suggested that calcium ions activate catecholamine synthesizing enzymes through intracerebral 
calmodulin (Sutoo et al., 1989). On the other hand, it was known that calcium supplements produce a significant 
reduction of blood pressure in healthy adults, and hypertensive subjects have a reduced concentration of ionized 
calcium in the serum. We have investigated the role of calcium ions in the regulation of blood pressure in the light of 
our previous reports and have suggested that central calcium reduces blood pressure through an intracerebral, 
calmodulin-dependent, ca echolamine-synthesizing system (Sutoo et al., 1987). Also, our study suggested that a part of 
the i.v. injected calcium might transfer to the intracerebral system and reduce blood pressure (Sutoo et al., 1988). The 
present study was carried out to clarify the effects of continuous oral intake (p.o.) of calcium on the central, 
catecholamine-dependent, i gulation of blood pressure. 
The adult male Wistar rats (270-340 g) were divided into 4 groups; the rats were administrated intraventricularly 
(i.c.v.) and continuously with either a-methyltyrosine (aMPT, inhibitor of tyrosine hydroxylase, 300/tg/12 pl/day) or 
saline by an osmotic mini-pump (Alza, CA), furthermore each rat group was given freely either tap water or 4~ (w/v) 
CaCI 2 solution. And the changes of the systolic blood pressure (SBP) were compared among rats groups every day by 
sphygmomanometer (Riken Kaihatsu, Japan). The SBP of rats supplemented orally with calcium dropped significantly 
from the 9th day compared to that of the control rats. On the other hand, aMPT attenuated the magnitude of 
calcium-induced hypotensive activity from the 16th day, although aMPT in itself did not cause any significant effects 
on SBP (Table 1). This study was reconfirmed by the examination of continuous i.p.-load of CaCI 2. Namely, SBP of 
rats admimstrated i.p. with CaCI 2 (36 mg/day) decreased gradually with the elapse of days, and was significantly 
changed from the 7th day compared to control evel. However, the SBP of rats continuously administrated i.c.v, with 
aMPT (300 is/tg/day) was not changed by the i.p. administration of CaCI2. 
Recently, we have reported (Sutoo et al., 1987) that i.c.v, administration of CaCI 2 produces a hypotensive r sponse 
in conscious rats. "l~tis effect was abolished by the administration of a calmodulin antagonist or an inhibitor of 
Table 1 
Effect of a-methyltyrosine on hypotensive r sponse induced by oral intake of CaC! 2 
Treatment After administration (day) 
p.o. i.c,.v. 1 5 9 11 12 14 16 18 
Water Saline 7.9±4.7 6.0±4.3 9.2±6.1 9.0±5.6 6.3±5.1 10.0±6.6 7.7±4.8 6.8±4.6 
Water aMPT -3.1±3.8 -5.1±4.1 -6.7±5.2 -5.7±5.0 -5.8±4.5 --4A±4.4 -3.3±3.5 -5.1±4.4 
CaCI 2 Saline 2.5±3.4 1.4±3.3 -19.7±5.1 b -26.7±4.9 b -29.6±4.2 b -35.7± 4.2b --~'9±4"0b --50"9±5"6b 
CaCI 2 aMPT 3.3±3.1 4.1±3.4 -4.8±4.6 -13.3±5.3 a -25.8±6.4 b -'28.1± 5.8b -31.0±5-1~ --30"1±5"4bd 
Values ~e me~s ± S.E. of 7 experiments. SBP values at each time were subtracted by Pre-ad~nistration value, a P < 0.05, b P < 0.01 
vs. water+safine;CP<0.05, dp<0.01vs. CaCl2+salinebyNewman -Keulst-test. 
